Optimal Endpoint of Therapy in IBD: An Update on Factors Determining a Successful Drug Withdrawal
Ulcerative colitis (UC) and Crohn’s disease (CD) are chronic inflammatory disorders, which require long term treatment to achieve remission and to prevent relapses and cancer. While current therapies are effective in most cases, they can have rare but serious side effects and are often associated wi...
Saved in:
Main Authors: | Anita Annaházi, Tamás Molnár |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2015-01-01
|
Series: | Gastroenterology Research and Practice |
Online Access: | http://dx.doi.org/10.1155/2015/832395 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Factors Predicting the Adherence to the Therapy of Italian IBD Patients
by: Cristina Bucci, et al.
Published: (2017-01-01) -
Role of 5-ASA in IBD Therapy
by: CN Williams
Published: (1994-01-01) -
Interprofessional approach to personalized medication management and therapy optimization in IBD care
by: Daniel Fleischmann, et al.
Published: (2025-01-01) -
Examination of non-conventional dysplasias adjacent to colorectal adenocarcinoma in patients with IBD
by: Szintia Almási, et al.
Published: (2025-01-01) -
Efficacy of umbilical cord-derived mesenchymal stem cells and exosomes in conjunction with standard IBD drug on immune responses in an IBD mouse model
by: Fatemeh Kheradmand, et al.
Published: (2025-01-01)